The reason for the tortoise pace is clear: there are just two people administering jabs
While this is one of the larger-scale vaccinations, the drive faces delays and pauses due to shortages of vaccines, especially in remote areas
Maharashtra, which would receive 50,000 doses in the next three days, has also got the largest supply of vaccines from the Centre
Vaccine doses acquired through PM-CARES Fund and the GAVI Covax facility were received in full and already utilised
SII aims to make 50 million doses of Covovax (the Novavax vaccine) per month at its Pune plant
Congress leader Rahul Gandhi hit out at the government's vaccine policy, saying it is compounding problems and demanded that the vaccine purchase should be centralised and distribution decentralised
The cumulative number of Covid-19 vaccine doses administered in the country reached nearly the 180 million mark as per the 8 pm provisional report
Amid multiple states reporting a shortage of COVID-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their production plan for the next four months, informing they can ramp it up to 10 crore and 7.8 crore doses respectively by August, official sources said on Wednesday The sources said the Union Health Ministry and the office of Drugs Controller General of India had sought from both the firms their production plan for June, July, August and September. The Hyderabad-based Bharat Biotech's indigenously developed Covaxin and Oxford-AstraZeneca's Covishield, being manufactured by the Pune-based Serum Institute of India, are currently being used in India's inoculation drive against coronavirus. Dr V Krishna Mohan, the Whole-time Director of Bharat Biotech, is learnt to have conveyed to the government that the production of Covaxin would be raised to 3.32 crore in July, and to 7.82 crore in August which will be maintained in September too. Similarly, Prakash Kum
Vaccine production should ramp up, June onwards, given that manufacturers are boosting capacities
The Centre has justified in the Supreme Court the COVID-19 vaccination policy saying its response and strategy is completely driven by expert medical and scientific opinion which leaves little room for judicial interference and emphasised that citizens of all age groups will get free vaccination throughout the country. In view of the unprecedented and peculiar circumstances under which vaccination drive is devised as an executive policy, the wisdom of the executive should be trusted, it said. In a global pandemic, where the response and strategy of the nation is completely driven by expert medical and scientific opinion, "any overzealous, though well-meaning judicial intervention, may lead to unforeseen and unintended consequences", the government said. In 218-page affidavit filed late Sunday night in the top court's suo motu case on COVID-19 management, the Centre said, this policy "conforms to mandate of Article 14 and Article 21 of the Constitution of India and is made after ...
The Centre has ruled out in the Supreme Court door-to-door vaccination of people and said the inoculation will be done at identified COVID Vaccination Centres (CVC)
Trust wisdom of the executive branch, says government in affidavit before court
America's top public health expert Dr Anthony Fauci has called for a scale-up in manufacture of coronavirus vaccines both domestically and globally to fight the deadly pandemic
Brihanmumbai Municipal Corporation (BMC) received a fresh stock of 100,000 Covid vaccine doses on Tuesday night and it will resume vaccination of people above 45 years at government centres.
Govt must no longer ignore scientific advice
The overtures are a blow to Indian Prime Minister Narendra Modi's much-touted vaccine diplomacy efforts earlier this year that were aimed at countering its larger neighbour, China.
The Association of Power Producers has asked the power ministry to treat all operational staff across the electricity supply value chain as a priority category for vaccination
The data showed that 150 million doses had been given to the states so far, of which 10 million were still available with them.
SII and Bharat Biotech had announced prices for state government procurement and for institutional sale to private hospitals
A new phase of vaccination begins on May 1, which will enable everyone above 18 to get vaccinated.